In addition, disruption in the IGF-1 axis during fetal development, resulting in fetal macrosomia, may create a metabolic predisposition to obesity [40,56], which can lead to IR and further increased risk for endocrine disorders. This evidence concerns the gene IGF1 and obesity disorder.